Kinderneusspray Xylometazoline Hcl Htp (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is indicated for temporary relief of nasal congestion by constricting blood vessels in the nasal mucosa across several upper‑respiratory conditions.

• Common cold: reduces swelling of nasal passages, improves airflow and eases breathing during viral upper‑respiratory infection.
• Sinusitis: diminishes nasal mucosal edema, helping to relieve blockage and pressure associated with sinus inflammation.
• Allergic rhinitis: lessens nasal congestion caused by allergen‑induced inflammation, supporting clearer breathing during exposure to pollen, dust or animal dander.

• Xylometazoline Hydrochloride acts as a selective alpha‑adrenergic receptor agonist on the smooth muscle of nasal mucosal blood vessels. Activation of α1‑ and α2‑adrenergic receptors induces vasoconstriction, which reduces blood flow and edema in the nasal lining. The resulting decrease in tissue swelling opens the nasal airway, providing rapid relief of congestion without significant systemic absorption.

Xylometazoline nasal spray may cause local or systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

• Nasal burning or stinging: mild irritation at the site of application.
• Sneezing: transient increase in sneezing immediately after use.
• Dry nasal mucosa: temporary dryness or crust formation within the nostrils.
• Headache: mild headache reported by some users.
• Nasal irritation: itching or tingling sensation.

Serious or Rare Side Effects

• Rebound congestion: worsening nasal blockage after continuous use beyond recommended duration.
• Hypertension: elevated blood pressure in susceptible individuals, especially with excessive dosing.
• Cardiac arrhythmia: irregular heartbeat reported rarely, particularly in patients with pre‑existing heart conditions.

Before using Xylometazoline nasal spray, consider the following precautions to ensure safe and effective use.

• Age restriction: not recommended for children under 6 years without medical advice.
• Duration of use: limit treatment to 3‑5 consecutive days to avoid rebound congestion.
• Cardiovascular disease: use with caution in patients with hypertension, coronary artery disease or arrhythmias.
• Pregnancy and lactation: safety not established; consult a healthcare professional before use.
• Drug interactions: avoid concurrent use with monoamine oxidase inhibitors or other nasal decongestants.
• Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight.

Xylometazoline may interact with certain medicines, affecting its safety or efficacy.

Major Interactions (Avoid)

• MAO inhibitors: risk of hypertensive crisis when combined with the vasoconstrictive effect.
• Other nasal decongestants: additive vasoconstriction may increase blood pressure and cause severe rebound congestion.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents: possible reduction in blood pressure control, requiring monitoring.
• Tricyclic antidepressants: may enhance vasoconstrictive effects, leading to increased cardiovascular strain.
• Beta‑blockers: monitor for heightened cardiovascular responses when used together.